These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 9728935
1. T-lymphopoietic capacity of cord blood-derived CD34+ progenitor cells. Gardner JP, Rosenzweig M, Marks DF, Harper D, Gaynor K, Fallon RJ, Wall DA, Johnson RP, Scadden DT. Exp Hematol; 1998 Sep; 26(10):991-9. PubMed ID: 9728935 [Abstract] [Full Text] [Related]
2. Detection of a CD4+CD8-CD3- cell subpopulation during the differentiation of cord blood CD34+ cells into T cells in vitro. Jin JG, Bai BJ, Yao ZJ, Wu RN, Feng K, Hu JW, Hu LD, Jiang M, Liao L, Chen H. Arch Immunol Ther Exp (Warsz); 2009 Sep; 57(3):213-9. PubMed ID: 19479205 [Abstract] [Full Text] [Related]
3. Complete TCR-delta rearrangements and partial (D-J) recombination of the TCR-beta locus in CD34+7+ precursors from human cord blood. Ktorza S, Blanc C, Laurent C, Sarun S, Verpilleux MP, Debré P, Schmitt C. J Immunol; 1996 Jun 01; 156(11):4120-7. PubMed ID: 8666778 [Abstract] [Full Text] [Related]
4. CD3 gamma, CD3 delta, and CD3 zeta mRNA in adult human marrow hematopoietic progenitors correlates with surface CD2 and CD7 expression. Long H, Gaffney P, Mortari F, Miller JS. Exp Hematol; 1996 Oct 01; 24(12):1402-8. PubMed ID: 8913286 [Abstract] [Full Text] [Related]
5. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice. Samira S, Ferrand C, Peled A, Nagler A, Tovbin Y, Ben-Hur H, Taylor N, Globerson A, Lapidot T. Stem Cells; 2004 Oct 01; 22(6):1085-100. PubMed ID: 15536198 [Abstract] [Full Text] [Related]
6. Arrest of in vitro T cell differentiation of normal bone marrow-derived CD34+ stem cells with thymic epithelial fragments from children with AIDS. Ruiz ME, Freeman J, Bouhasin JD, Knutsen AP, Hendrix MJ. Stem Cells; 1996 Sep 01; 14(5):533-47. PubMed ID: 8888494 [Abstract] [Full Text] [Related]
7. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments. Ruiz M, Roodman ST, Bouhasin JD, Knutsen AP. Stem Cells; 1996 Jan 01; 14(1):132-45. PubMed ID: 8820959 [Abstract] [Full Text] [Related]
8. Expression of stromal cell-derived factor-1/pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34+ human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors. Ishii T, Nishihara M, Ma F, Ebihara Y, Tsuji K, Asano S, Nakahata T, Maekawa T. J Immunol; 1999 Oct 01; 163(7):3612-20. PubMed ID: 10490954 [Abstract] [Full Text] [Related]
9. Prethymic CD34+ progenitors capable of developing into T cells are not committed to the T cell lineage. Blom B, Res P, Noteboom E, Weijer K, Spits H. J Immunol; 1997 Apr 15; 158(8):3571-7. PubMed ID: 9103417 [Abstract] [Full Text] [Related]
11. Ex vivo expansion does not alter the capacity of umbilical cord blood CD34+ cells to generate functional T lymphocytes and dendritic cells. Kobari L, Giarratana MC, Gluckman JC, Douay L, Rosenzwajg M. Stem Cells; 2006 Sep 15; 24(9):2150-7. PubMed ID: 16946001 [Abstract] [Full Text] [Related]
12. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood. Huang S, Law P, Young D, Ho AD. Exp Hematol; 1998 Nov 15; 26(12):1162-71. PubMed ID: 9808056 [Abstract] [Full Text] [Related]